Evidence map›Paper›PMID 14530379›Full record

ArticleThe Journal of experimental medicine2003

The strength of persistent antigenic stimulation modulates adaptive tolerance in peripheral CD4+ T cells.

Nevil J Singh, Ronald H Schwartz

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 93 citations in OpenAlex.

  1. Trial
  2. Review
  3. Epitope-based precision immunotherapy of Type 1 diabetes.Human vaccines & immunotherapeutics · 2023
    Article
  4. Article
  5. Perfect adaptation of CD8Science signaling · 2021
    Article
  6. CD4AIDS research and human retroviruses · 2018
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nevil J SinghLaboratory of Cellular and Molecular Immunology, NIAID/NIH, Building 4, Room 111, 4 Center Drive MSC-0420, Bethesda, MD 20892, USA.
Ronald H Schwartz
National Institutes of Health · US

Funding

T Cell ActivationZIAAI000485 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SCHWARTZ, RONALD · 2009 to 2013
$4.3M
T CELL ACTIVATIONZ01AI000485 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI SCHWARTZ, RONALD · 1987 to 2008
$2.6M
6 · The paper itself

Abstract

The quantitative adaptation of receptor thresholds allows cells to tailor their responses to changes in ambient ligand concentration in many biological systems. Such a cell-intrinsic calibration of T cell receptor (TCR) sensitivity could be involved in regulating responses to autoantigens, but this has never been demonstrated for peripheral T cells. We examined the ability of monoclonal naive T cells to modulate their responsiveness differentially after exposure to fourfold different levels of persistent antigen stimulation in vivo. T cells expanded and entered a tolerant state with different kinetics in response to the two levels of stimulation, but eventually adjusted to a similar slow rate of turnover. In vivo restimulation revealed a greater impairment in the proliferative ability of T cells resident in a higher antigen presentation environment. We also observed subtle differences in TCR signaling and in vitro cytokine production consistent with differential adaptation. Unexpectedly, the system failed to similarly compensate to the persistent stimulus in vivo at the level of CD69 expression and actin polymerization. This greater responsiveness of T cells residing in a host with a lower level of antigen presentation allows us to demonstrate for the first time an intrinsic tuning process in mature T lymphocytes, albeit one more complex than current theories predict.

Indexed as

Immune ToleranceAdaptation, PhysiologicalAnimalsAntigen PresentationAntigensAntigens, CDAntigens, Differentiation, T-LymphocyteCD4-Positive T-LymphocytesCD69 AntigensColumbidaeCytochrome c GroupInterferon-gammaInterleukin-2Lectins, C-TypeLymphocyte ActivationMiceAntigensAntigens, CDAntigens, Differentiation, T-LymphocyteCD69 AntigensCytochrome c GroupInterferon-gammaInterleukin-2Lectins, C-TypeReceptors, Antigen, T-Cell

Identifiers

PMID14530379
PMCPMC2194218
OpenAlexW2130797204

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.